Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Feb 2026 for C4 Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Scott N. Boyle: trading record in brief
Scott N. Boyle is a declared insider of C4 Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 10 filings, for trades running from 25 May 2022 to 13 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 18 February 2026 came the latest disclosure, a share grant in C4 Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott N. Boyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
200,000 shares0Common StockSEC:0001470831-26-000180:0
1,735 shares@ US$3.2023.2% of flowCommon StockSEC:0001662579-25-000019:0
3,750 sharesCommon StockSEC:0001662579-24-000104:0
2,250 sharesCommon StockSEC:0001662579-24-000083:0
1,735 shares@ US$6.5345.6% of flowCommon StockSEC:0001662579-24-000015:0
2,250 sharesCommon StockSEC:0001662579-23-000081:0
20,000 shares0Common StockSEC:0001662579-23-000037:0
3,750 sharesCommon StockSEC:0001662579-23-000022:0
1,102 shares@ US$7.0131.2% of flowCommon StockSEC:0001209191-22-036711:0
3,750 sharesCommon StockSEC:0001209191-22-032510:0
10 of 10 declarations
